We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, Congress in Tandem Push More Drug Innovation Progress
FDA, Congress in Tandem Push More Drug Innovation Progress
Stronger public-private partnerships, a streamlined clinical trials process, more funding for the FDA and beefed up safeguards on intellectual property are some of the ways to improve drug innovation, experts from government and industry said yesterday.